<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: ra--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">11720432</article-id><article-id pub-id-type="pmc">2363932</article-id><article-id pub-id-type="pii">6692116</article-id><article-id pub-id-type="doi">10.1054/bjoc.2001.2116</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jordh&#x000f8;y</surname><given-names>M S</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fayers</surname><given-names>P</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Loge</surname><given-names>J H</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Saltnes</surname><given-names>T</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ahlner-Elmqvist</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kaasa</surname><given-names>S</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Unit of Applied Clinical Research, University Hospital of Trondheim, NTNU, 5. etg., Kreftbygget, Trondheim, N-7006, Norway</aff><aff id="aff2"><label>2</label>Unit of Applied Clinical Research, NTNU, Trondheim, Norway</aff><aff id="aff3"><label>3</label>Unit of Applied Clinical Research, NTNU, Trondheim</aff><aff id="aff4"><label>4</label>Department of Oto-Rhino-Laryngology, Malm&#x000f6; University Hospital, Malm&#x000f6;, S-20502, Sweden</aff><aff id="aff5"><label>5</label>Palliative Medicine Unit, Department of Radiotherapy and Oncology, University Hospital of Trondheim and Unit of Applied Clinical Research, NTNU, 5 etg. Kreftbygget, RiT, Trondheim, N-7006, Norway</aff><aff id="aff6"><label>6</label>Department of Public Health, Aberdeen Medical School, Aberdeen, AB25 2ZD, UK</aff><aff id="aff7"><label>7</label>Department of Behavioral Sciences in Medicine, University of Oslo, p.b. 1111 Blindern, Oslo, 0317</aff><pub-date pub-type="ppub"><month>11</month><year>2001</year></pub-date><volume>85</volume><issue>10</issue><fpage>1478</fpage><lpage>1485</lpage><history><date date-type="received"><day>12</day><month>03</month><year>2001</year></date><date date-type="rev-recd"><day>25</day><month>07</month><year>2001</year></date><date date-type="accepted"><day>30</day><month>07</month><year>2001</year></date></history><copyright-statement>Copyright 2001, Cancer Research Campaign</copyright-statement><copyright-year>2001</copyright-year><permissions><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><abstract><p>Population-based surveys have shown that health-related quality of life (HRQL) is influenced by patients' characteristics such as age, gender, living situation and diagnoses. The present study explores the impact of such factors on the HRQL of severely ill cancer patients. The study sample included 395 cancer patients who participated in a cluster randomised trial of palliative care. Median survival was 13 weeks. HRQL assessments (using the EORTC QLQ-C30 questionnaire) were compared among subgroups of relevant patients' characteristics (ANOVA), and the significance of individual covariates was explored by multivariate linear regression. Most EORTC QLQ-C30 scores showed minor differences between genders. Higher age was associated with less sleeping disturbance, less pain and better emotional functioning. No positive impact of living with a partner was found. Performance status and/or time from assessment to death were significantly associated with most functioning and symptom scores. We concluded that although the overall impact of sociodemographic characteristics may seem less important to HRQL scores among advanced cancer patients than in general populations, age and gender should be allowed for. Performance status and closeness to death also need to be reported. &#x02002;&#x02002;<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.bjcancer.com">http://www.bjcancer.com</ext-link> &#x000a9; 2001 Cancer Research Campaign</p></abstract><kwd-group><kwd>palliative care</kwd><kwd>cancer</kwd><kwd>quality of life</kwd><kwd>predictive factors</kwd></kwd-group></article-meta></front></article>


